XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders’ Equity (Tables) | 6 Months Ended
--- | ---
Aug. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Stock Option Activity | Option activity for the six months ended August 31, 2025 and the year ended February 28, 2025 was as follows: Schedule of Stock Option Activity
|  | Options |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |  |  | Aggregate Intrinsic Value ($) |
Options outstanding at February 29, 2024 |  |  | 85,300 |  |  |  | 60.50 |  |  |  | 2.52 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (8,958 | ) |  |  | 125.65 |  |  |  | - |  |  |  | - |
Options outstanding at February 28, 2025 |  |  | 76,342 |  |  |  | 52.69 |  |  |  | 1.60 |  |  |  | - |
Granted |  |  | 806,250 |  |  |  | 4.60 |  |  |  | 2.68 |  |  |  | 200,844 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (76,342 | ) |  |  | 52.69 |  |  |  | - |  |  |  | - |
Options outstanding August 31, 2025 |  |  | 806,250 |  |  |  | 4.60 |  |  |  | 2.68 |  |  |  | 200,844 |
Options expected to vest in the future as of August 31, 2025 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Options exercisable at August 31, 2025 |  |  | 806,250 |  |  |  | 4.60 |  |  |  | 2.68 |  |  |  | 200,844 |
Options vested, exercisable, and options expected to vest at August 31, 2025 |  |  | 806,250 |  |  |  | 4.60 |  |  |  | 2.68 |  |  |  | 200,844 |
Schedule of Warranty Activity | Warrant activity for the six months ended August 31, 2025 and the year ended February 28, 2025 was as follows: Schedule of Warranty Activity
|  | Warrants |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |
Warrants outstanding at February 29, 2024 |  |  | 486,165 |  |  |  | 9.94 |  |  |  | 1.96 |
Granted |  |  | 2,637,887 |  |  |  | 4.80 |  |  |  | 4.24 |
Exercised |  |  | (104,965 | ) |  |  | 3.02 |  |  |  | - |
Forfeited or cancelled |  |  | (3,202 | ) |  |  | 108.37 |  |  |  | - |
Warrants outstanding at February 28, 2025 |  |  | 3,015,885 |  |  |  | 5.36 |  |  |  | 3.84 |
Granted |  |  | 186,887 |  |  |  | 4.13 |  |  |  | 4.62 |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (5,031 | ) |  |  | 226.00 |  |  |  | - |
Warrants outstanding at August 31, 2025 |  |  | 3,197,741 |  |  |  | 4.93 |  |  |  | 3.42 |
Warrant [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Share Based Payments Award Stock Options Valuation Assumptions | The fair value of warrants issued during the six months ended August 31, 2025 was estimated using the Black-Scholes model with the following assumptions. There were no warrants issued for the six months ended August 31, 2024: Assumptions: Schedule of Share Based Payments Award Stock Options Valuation Assumptions
|  | 2025 |
Dividend yield |  |  | 0.0 | %
Risk-free interest rate |  |  | 3.8%-4.1 | %
Expected volatility |  |  | 141.5%-160.5 | %
Expected life (in years) |  |  | 4.62 |
Share-Based Payment Arrangement, Option [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Share Based Payments Award Stock Options Valuation Assumptions | The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the six months ended August 31, 2025. There were no grants issued during the three months ended August 31, 2024: Schedule of Share Based Payments Award Stock Options Valuation Assumptions
|  | 2025 |
Dividend yield |  |  | 0.0 | %
Risk-free interest rate |  |  | 3.83%-4.08 | %
Expected volatility |  |  | 122.5.0%-139.7 | %
Expected life (in years) |  |  | 2.68 |
Stock Appreciation Rights [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Schedule of Stock Option Activity | SARs activity for the six months ended August 31, 2025 and the year ended February 28, 2025 was as follows: Schedule of Stock Option Activity
|  | SARs |  |  | Weighted Average Exercise Price ($) |  |  | Weighted Average Remaining Contractual Life (Yrs.) |  |  | Aggregate Intrinsic Value ($) |
SARs outstanding at February 29, 2024 |  |  | 40,390 |  |  |  | 44.77 |  |  |  | 2.99 |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (167 | ) |  |  | 37.40 |  |  |  | - |  |  |  | - |
SARs outstanding at February 28, 2025 |  |  | 40,223 |  |  |  | 44.80 |  |  |  | 1.99 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited or cancelled |  |  | (3,907 | ) |  |  | 52.60 |  |  |  | - |  |  |  | - |
SARs outstanding August 31, 2025 |  |  | 36,316 |  |  |  | 43.96 |  |  |  | 1.66 |  |  |  | - |
SARs expected to vest in the future as of August 31, 2025 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
SARs exercisable at August 31, 2025 |  |  | 36,316 |  |  |  | 43.96 |  |  |  | 1.66 |  |  |  | - |
SARs vested, exercisable, and SARs expected to vest at August 31, 2025 |  |  | 36,316 |  |  |  | 43.96 |  |  |  | 1.66 |  |  |  | - |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |